Impact of Promogran Prisma on pain of split-thickness skin graft donor sites compared to standard of care alone a pilot study

Brief description of study

The purpose of this study is to determine whether a product called Promogran PrismaTM lowers the amount of pain you have at the donor site for your graft (the area where the skin is taken from). Promogran Prisma is an FDA-approved composite collagen-silver-oxidized regenerated cellulose dressing in the form of a sheet that can be placed onto the donor site. It works by keeping the donor site moist in order to promote wound healing.


Clinical Study Identifier: s19-00437
ClinicalTrials.gov Identifier: NCT04050124
Principal Investigator: Scott A Gorenstein
Currently Recruiting

Contact the research team to learn more about this study.


By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.